TRIDENT LIFELINE
|
The Current P/S Ratio of TRIDENT LIFELINE is 3.91.
| Share Price | ₹303.9 | Jan 27,2026 |
| Market Cap | ₹361.6 Cr | |
| Sales-TTM | ₹92.5 Cr | TTM-Consolidated Results |
| Price/Sales | 3.91x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of TRIDENT LIFELINE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹361.6 Cr] as on Jan 27,2026
(/) Sales [ ₹92.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.91x ]
Thus, for TRIDENT LIFELINE , the investors are currently willing to pay '3.91 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of TRIDENT LIFELINE !
The chart below summarizes the trend in P/S Ratio of TRIDENT LIFELINE over the last five years.
Historical PS (Price/Sales) ratio chart of TRIDENT LIFELINE
PS Ratio Performance Analysis for TRIDENT LIFELINE
- TRIDENT LIFELINE 's p/e ratio for fiscal years ending Mar2025 to Mar2022 averaged 3.35x.
- TRIDENT LIFELINE 's operated at median p/e ratio of 4.22x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, TRIDENT LIFELINE 's p/e ratio peaked in Mar2023 at 5.77x.
- TRIDENT LIFELINE 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does TRIDENT LIFELINE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| TRIDENT LIFELINE | 92.5 | 3.91 | 361.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.16 | 393,323.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.04 | 160,825.0 |
| CIPLA LTD | 28,351.1 | 3.74 | 106,048.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.05 | 135,349.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.98 | 103,494.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.37 | 86,451.7 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.67 | 89,902.0 |
| LUPIN LTD | 24,750.7 | 3.96 | 98,102.1 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.02 | 65,639.3 |
| ABBOTT INDIA LTD | 6,714.4 | 8.76 | 58,827.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TRIDENT LIFELINE 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.02x |
| Max industry PS | 16.04x |
| Median industry PS | 3.96x |
| Average industry PS | 6.33x |
You may also like the below Video Courses